1Wk·

Loser Johnson & Johnson

$JNJ (-0.18%)

The ongoing lawsuits over allegedly carcinogenic talcum powder products have put Johnson under pressure.

A US federal judge has refused to resolve the matter via insolvency proceedings.

The financial risk at Johnson is high, new uncertainty in the strategic direction.

Johnson the new Bayer $BAYN (+1.53%) and 3M $MMM (+0.09%) ?


Bottomless pit, the share has been in a volatile downward trend since 2022. Once again, the upper boundary line was not broken.

attachment
5
15 Comments

profile image
have been thinking about selling for weeks to be honest
i think my money would be better spent elsewhere
$KRYS $NBIX $ATCO B $PRY
1
profile image
@Memo0606
$CORT
P/E ratio falls to 12
2
profile image
@Memo0606
My friend, what is your plan for the new week?
profile image
@Tenbagger2024 sell a few stocks
among the candidates for sale are
$JNJ
$FMG
$6367
2
profile image
@Memo0606
When will the position at Prismian be filled?
2
profile image
@Tenbagger2024 i want to fill these up with the sales
my friend
which values would you sell
i would like to buy my existing assets
please help me
1
profile image
@Memo0606
https://getqu.in/V8ZekW/

What's going on at Johnson?
Maybe a reason to sell
2
profile image
@Memo0606
You actually have good companies in your portfolio.
But I still don't see why Mongo's share price should rise. Profit growth is declining
1
profile image
profile image
@Tenbagger2024 I am convinced by mongo
what would you kick out after j&j no h?
profile image
@Memo0606
Prologis doesn't convince me either. Unless the dividend yield is important to you
1
View all 2 further answers
profile image
It's not the first time they've been the center of attention I just watched a series The Tylenol Murders on Netflix was also made there
1
Join the conversation